Evidence map›Paper›PMID 34331511›Full record

ArticleTransboundary and emerging diseases2022

Field evaluation of specific mycobacterial protein-based skin test for the differentiation of Mycobacterium bovis-infected and Bacillus Calmette Guerin-vaccinated crossbred cattle in Ethiopia.

Berecha Bayissa, Asegedech Sirak, Aboma Zewude, Adane Worku, Balako Gumi, Stefan Berg, R Glyn Hewinson, James L N Wood, Gareth J Jones, ETHICOBOTS consortium and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 4 countries.

Berecha BayissaAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Asegedech SirakAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Aboma ZewudeEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Adane WorkuAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0003-3106-3832
Balako GumiAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
Stefan BergDepartment of Bacteriology, Animal and Plant Health Agency, New Haw, Addlestone, Surrey, UK.
R Glyn HewinsonAberystwyth University, Ceredigion, UK.
James L N WoodDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Gareth J JonesDepartment of Bacteriology, Animal and Plant Health Agency, New Haw, Addlestone, Surrey, UK.
ETHICOBOTS consortium
H Martin VordermeierDepartment of Bacteriology, Animal and Plant Health Agency, New Haw, Addlestone, Surrey, UK.
Gobena AmeniAklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0003-3987-0671
Aberystwyth University · GBAddis Ababa University · ETAnimal and Plant Health Agency · GBAmhara Regional Health Bureau · ETEthiopian Public Health Institute · ETNational Veterinary Institute · ETUnited Arab Emirates University · AEUniversity of Cambridge · GB

Funding

Ethiopia-Emory TB Research Training ProgramD43TW009127 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Kidist Bobosha · 2013 to 2026
$3.4M
Biotechnology and Biological Sciences Research CouncilDepartment for International Development, UK GovernmentEconomic and Social Research CouncilFIC NIH HHS D43 TW009127Medical Research CouncilThe Defense Science and Technology Laboratory
6 · The paper itself

Abstract

Bovine tuberculosis (bTB) challenges intensive dairy production in Ethiopia and implementation of the test and slaughter control strategy is not economically acceptable in the country. Vaccination of cattle with Bacillus Calmette-Guerin (BCG) could be an important adjunct to control, which would require a diagnostic test to differentiate Mycobacterium bovis (M. bovis)-infected and BCG-vaccinated animals (DIVA role). This study describes an evaluation of a DIVA skin test (DST) that is based on a cocktail (DSTc) or fusion (DSTf) of specific (ESAT-6, CFP-10 and Rv3615c) M. bovis proteins in Zebu-Holstein-Friesians crossbred cattle in Ethiopia. The study animals used were 74 calves (35 BCG vaccinated and 39 unvaccinated) aged less than 3 weeks at the start of experiment and 68 naturally infected 'TB reactor' cows. Six weeks after vaccination, the 74 calves were tested with the DSTc and the single intradermal cervical comparative tuberculin (SICCT) test. The TB reactor cows were tested with the DSTc and the SICCT test. Reactions to the DSTc were not observed in BCG-vaccinated and unvaccinated calves, while SICCT test reactions were detected in vaccinated calves. DSTc reactions were detected in 95.6% of the TB reactor cows and single intradermal tuberculin positive reactions were found in 98.2% (95% confidence interval, CI, 92.1-100%). The sensitivity of the DSTc was 95.6% (95% CI, 87.6-99.1%), and significantly (p < .001) higher than the sensitivity (75%, 95% CI, 63.0-84.7%) of the SICCT test at 4 mm cut-off. DSTf and DSTc reactions were correlated (r = 0.75; 95% CI = 0.53-0.88). In conclusion, the DSTc could differentiate M. bovis-infected from BCG-vaccinated cattle in Ethiopia. DST had higher sensitivity than the SICCT test. Hence, the DSTc could be used as a diagnostic tool for bTB if BCG vaccination is implemented for the control of bTB in Ethiopia and other countries.

Indexed as

Cattle DiseasesMycobacterium bovisTuberculosis, BovineAnimalsBCG VaccineCattleEthiopiaFemaleTuberculinTuberculin TestVaccinationBCG VaccineTuberculinBCG vaccinationbovine tuberculosiscrossbred cattleDIVA skin testspecific mycobacterial proteins

Identifiers

PMID34331511
PMCPMC8801543
OpenAlexW3184693940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.